Our study found PMP22 variants, including duplication and point mutation, accounting for 69.2% of the identified genetic patients and 29% with sensorimotor neuropathy, comparable to previous studies (Bis‐Brewer et al., 2020). This evidence concerns the gene PMP22 and Sensorimotor neuropathy.